Posts by Sandra Ansanay-Alex
Covid-19 Research: Aerium Therapeutics begins development of three in-licensed antibodies
Aerium Therapeutics, a company based in Lausanne and Boston, focuses on the development of antiviral therapeutics for COVID-19 and emerging viral threats. Aerium Therapeutics announced that it has licensed and begun development of three monoclonal antibodies (mAbs) with broad and potent activity against the predominant variants of SARS-CoV-2 (the virus that causes COVID-19),…
Read MoreCancer Research: HES-SO Valais-Wallis and Debiopharm sign a partnership
The Life Technologies Institute of the Haute École d’Ingénierie has signed a new five-year collaboration agreement with Debiopharm Research & Manufacturing S.A. in Martigny. Funded to the extent of CHF 1.1 million by Debiopharm, with the possibility of a further CHF 1 million bonus, this joint research project aims to revolutionise the preparation of conjugates…
Read MoreCancer Research: ISREC Foundation and EPFL announce the creation of the Paternot Chair
The chair will be held by Professor Nicolas Thomä. The ISREC Foundation is contributing to the funding of the Chair with a donation of CHF 7.5 million. The Chair is named in memory of Yves Paternot, a tireless patron of the arts and President of the ISREC Foundation who passed away in 2016, and whose…
Read MoreHeroSupport wins a CHF 150,000 Venture Kick Grant
The HUG and UNIGE spin-off wants to improve cancer treatment universal access with tailored patient-positioning medical devices and standardized workflows. The Venture Kick Grant stage 2 will help the medtech start-up bring the product to its first customers. Breast cancer which affects 1 out of 8 women. Radiotherapy is an effective treatment, but…
Read MoreTune Insight raises CHF 3,1 Million
The round is led by 14Peaks Capital, with participation from investors including Inflection.xyz, Debiopharm Innovation Fund and Zurich Cantonal Bank. Existing investor Wingman Ventures has also contributed. How to share data, without sharing it, and still be compliant with RGPD and data protection laws. Tune Insight is working on a solution! The EPFL…
Read MoreForum EPFL + Startup Day
Forum EPFL is taking place from 6 to 10 October 2025 at the SwissTech Convention Center. In October 2025, the Forum EPFL celebrate ists 43rd anniversary and remains one of the biggest job fairs in Europe, improving its services on a yearly basis. The Forum’s goal is to facilitate the students’ transition between studies…
Read MoreNagi Bioscience secures CHF 12.4 Million Investment
Nagi Bioscience, a Swiss life sciences company developing next-generation laboratory equipment to unlock the full potential of alternatives to animal testing. The company announces the successful closure of its Series A funding round. It has secured an oversubscribed 12.4M CHF investment from top-tier venture capital firms across Europe, co- led by Swisscanto and…
Read MoreDebiopharm Innovation Fund: a new seed fund dedicated to Digital Health
Debiopharm Innovation Fund, the strategic investment arm of Swiss biopharmaceutical company Debiopharm, with $150 million under management, announces the launch of its new seed funding initiative. It plans to deploy additional capital to support up to 15 seed-stage startups each year. Building on its strong track record of investing in 25 companies since…
Read MoreAtinary Technologies raises CHF 4.6 Million
The Biopôle-based start-up has developed a machine learning platform dedicated to materials discovery. The seed-round was round led by AgFunder and supported by Cherubic Ventures. Atinary is dedicated to accelerating R&D and discovery across diverse industries, including pharmaceuticals, biotechnology, chemicals, energy, electronics, cosmetics, and food via its cutting-edge, no-code platform SDLabs. This investment will…
Read MoreFuture Health Grant – 9 new projects selected
This great Swiss Health Valley🇨🇭 initiative was started by CSS and EPFL Innovation Park to promote Medicine 3.0. The 9 projects of the new cohort will receive between CHF 10,000 and CHF 50,000 as well as support and coaching. Allians Allergy Allergix – Digital solution enabling healthcare professionals to protect their patients against…
Read More